Randomized, controlled study on the effects of hypoxia exposure on shortness of breath and fatigue
A recently published randomized controlled trial (PubMed ID 39127085) examined the effects of intermittent hypoxia therapy (IHT) in individuals with post-acute COVID-19 sequelae (PASC / Long COVID). The aim was to determine whether repeated episodes of hypoxia can improve respiratory function and subjective well-being.
Study Design
-
Number of participants: 95 people with long COVID symptoms (shortness of breath and fatigue)
-
Grouping: Two groups—an intervention group with IHT and a control group with normoxia
-
Protocol: 5 minutes of hypoxia alternating with 5 minutes of normal air, for a total of five cycles per session
-
Duration of training: several sessions over two weeks
-
Outcome Measures: Shortness of breath, fatigue, lung function (FVC, FEV1), and exercise capacity (6-minute walk test)
Results
The researchers reported several significant improvements in the IHT group compared to the control group:
-
📈 Improved lung function: Increase in forced vital capacity (FVC) and forced expiratory volume (FEV1)
-
🚶 Increased endurance: The 6-minute walk distance (6MWD) increased significantly
-
🌬️ Subjective improvements: Participants reported less shortness of breath and less fatigue
-
⏱️ Dose-response relationship: Participants who underwent IHT for more than 10 days showed the greatest progress
-
⚕️ Safety: No serious side effects were observed
Significance of the Results
The results suggest that intermittent exposure to hypoxia could be a safe and promising approach for investigating Long COVID-associated symptoms such as shortness of breath and fatigue. However, the authors emphasize that further studies with larger sample sizes are needed to confirm these findings and better understand the underlying mechanisms.
Practical Application
The protocol used in the study is similar to the principle of interval hypoxia-hyperoxia training (IHHT), which can also be implemented using the MITOVIT® hypoxia training system.
Such controlled oxygen stimuli have been used for years in research, sports, and medicine to measurably analyze the body’s adaptive mechanisms.
Conclusion
The study shows that controlled hypoxia stimulation could open up new avenues of research into Long COVID—particularly with regard to resilience, respiratory function, and subjective well-being.
To the original publication: PubMed – ID 39127085
To learn more about MITOVIT® IHHT, visit www.mitovit.de